RPB0220

Pathogen Description

Target Pathogen Pathogen Name NCBI Taxonomy ID Order Family Genus Species Pathogen type
Pseudomonas aeruginosa Pseudomonas aeruginosa, Bacterium aeruginosum, Bacillus aeruginosus 287 Pseudomonadales Pseudomonadaceae Pseudomonas Pseudomonas aeruginosa Bacterium

Primer Description

Primer Name Sequence(5'-3') Length(bp) Primer Final Concentration(μM) GC Content(%) Predicted Melting Temperature(℃) Molecular Weight(g/moles) Positions in GenBank accession number
arr-F TTCCCATCTCTCATGATAATTACAAGCAGG 30 10μM 40 57.74 9694.51 \
arr-R CGACTTGAACGATACAGTGACAGACCGGAGCT 32 10μM 53.1 66.21 10436.97 \
arr-P CATGTTAACATAGATGTCATAATCACACCCIFAM-dt[THF][BHQ-dt]AGGATAAAACCGCC [3'-block] 75 10μM 40.9 63.85 13445.83 \

Gene Description

Target Gene GenBank ID
arr gene NC_002516

Assay Description

Application Assay Primer Designing Software Reaction Time(min) Assay Temperature(℃) Readout System(s) Limit of Detection(LoD) Sensitivity(%) Specificity(%)
a high-speed platform based on RAA technology to detect the resistance genes oprD\arr in P. aeruginosa isolates RAA NCBI’s Primer-BLAST program 5-20 39°C \ 10 copies \ \

Publication Description

Year of Publication Title Author(s) Journal PMID DOI
2024 Recombinase-aided amplification assay for rapid detection of imipenem-resistant Pseudomonas aeruginosa and rifampin-resistant Pseudomonas aeruginosa Yao Zhou,Ruiqing Shi,Liang Mu,Linlin Tian,Mengshan Zhou,Wenhan Lyu,Yaodong Chen Frontiers In Cellular And Infection Microbiology 39318475 10.3389/fcimb.2024.1428827

Recombinase-aided amplification assay for rapid detection of imipenem-resistant Pseudomonas aeruginosa and rifampin-resistant Pseudomonas aeruginosa

Author(s):

Yao Zhou,Ruiqing Shi,Liang Mu,Linlin Tian,Mengshan Zhou,Wenhan Lyu,Yaodong Chen

Journal:

Frontiers In Cellular And Infection Microbiology

Year:

2024

Abstract:

The indiscriminate use of antibiotics has resulted in a growing resistance to drugs in Pseudomonas aeruginosa. The identification of antibiotic resistance genes holds considerable clinical significance for prompt diagnosis. In this study, we established and optimized a Recombinase-Aided Amplification (RAA) assay to detect two genes associated with drug resistance, oprD and arr, in 101 clinically collected P. aeruginosa isolates. Through screening for the detection or absence of oprD and arr, the results showed that there were 52 Imipenem-resistant P. aeruginosa (IRPA) strains and 23 Rifampin-resistant P. aeruginosa (RRPA) strains. This method demonstrated excellent detection performance even when the sample concentration is 10 copies/μL at isothermal conditions and the results could be obtained within 20 minutes. The detection results were in accordance with the results of conventional PCR and Real-time PCR. The detection outcomes of the arr gene were consistently with the resistance spectrum. However, the antimicrobial susceptibility results revealed that 65 strains were resistant to imipenem, while 49 strains sensitive to imipenem with oprD were identified. This discrepancy could be attributed to genetic mutations. In summary, the RAA has higher sensitivity, shorter time, and lower-cost instrument requirements than traditional detection methods. In addition, to analyze the epidemiological characteristics of the aforementioned drug-resistant strains, we conducted Multilocus Sequence Typing (MLST), virulence gene, and antimicrobial susceptibility testing. MLST analysis showed a strong correlation between the sequence types ST-1639, ST-639, ST-184 and IRPA, while ST-261 was the main subtype of RRPA. It was observed that these drug-resistant strains all possess five or more virulence genes, among which exoS and exoU do not coexist, and they are all multidrug-resistant strains. The non-coexistence of exoU and exoS in P.aeruginosa is related to various factors including bacterial regulatory mechanisms and pathogenic mechanisms. This indicates that the relationship between the presence of virulence genes and the severity of patient infection is worthy of attention. In conclusion, we have developed a rapid and efficient RAA (Recombinase-Aided Amplification) detection method that offers significant advantages in terms of speed, simplicity, and cost-effectiveness (especially in time and equipment aspect). This novel approach is designed to meet the demands of clinical diagnostics.